Published in Cancer Weekly, September 26th, 2000
In fact, medical practitioners who find increased expression of this growth factor could potentially identify colorectal cancer patients who are node-negative but need adjuvant cancer therapies, E. Tsiompanou and colleagues reported at the British Cancer Research Meeting 2000.
The title of their presentation was "Immunohistochemical Expression of Vascular Endothelial Growth Factor (VEGF) and Vessel Counting as Prognostic Indicators in Node-Negative Colorectal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.